
















Sustainable public health systems 
for rare diseases
Rita Maria Ferrelli1, Amalia Egle Gentile2, Marta De Santis2 and Domenica Taruscio2
1Servizio Relazioni Esterne e Centro Rapporti Internazionali, Istituto Superiore di Sanità, Rome, Italy 
2Centro Nazionale Malattie Rare, Istituto Superiore di Sanità, Rome, Italy
Ann Ist Super Sanità 2017 | Vol. 53, No. 2: 170-175
DOI: 10.4415/ANN_17_02_16
Abstract
Introduction. In the framework of the Joint Action for Rare Diseases (RD-ACTION), 
a specific task was defined to identify mechanisms influencing sustainability, equity and 
resilience of health systems for rare diseases (RDs). 
Method. Literature narrative review on health systems sustainability and resilience for 
RDs. Years: 2000-2015. Databases: PubMed, Scopus, EBSCOHost, EMBAL, PAS-
CAL, EMBASE, STN International and GoogleScholar. Analysis: interpretive synthesis 
concept and thematic analysis (Dixon-Wood, et al.).
Results. 97 papers and 4 grey literature publications were identified. Two main topics 
stand out: economic evaluation and networks. The first topic did not identify widely ac-
cepted criterion to assign more weight to individuals with greater health needs. Health-
care network are identified as increasingly important for sustainability and resilience, in 
all of their aspects: professional “expertise”, “experience” networks of users and carers; 
policy, learning, and interest networks.
Conclusion. Possible mechanisms for ensuring sustainability can be identified in net-
working, patients’ empowerment and reorienting healthcare towards integrated com-
munity and home care.
INTRODUCTION
In recent years, European countries have been in-
volved in international projects and activities on Rare 
Diseases (RDs) aiming to accelerate scientific research 
and attain the overarching goal of improving the health 
outcomes of people affected by these diseases. The 
implementation of an European Member States (EU-
MSs) integrated approach to RDs calls for more com-
prehensive public health policies addressing the issue 
of sustainability. This can be achieved through a series 
of policy communication activities, building on other 
EU public health policy activities. Actually, the ongoing 
implementation of a better comprehensive approach to 
RDs is leading to the development of public health poli-
cies more appropriate. Capitalising on experience and 
work carried out over recent years, and with a view to 
further developing approaches at EU level, the Commu-
nication from the European Commission on effective, 
accessible and resilient health systems focuses on ac-
tions to strengthen the effectiveness of health systems, 
increase the accessibility of healthcare and improve the 
resilience of health systems. In relation to the resilience, 
and building on experience of recent reforms, the Com-
mission has identified the resilience factors that helped 
some health systems safeguard accessible and effective 
healthcare services for their population, namely: stable 
funding mechanisms, sound risk adjustment methods, 
good governance, information flows, adequate costing 
of health services, a health workforce of adequate capac-
ity and with the right skills [1]. They are explained as: 
• stable funding mechanisms: it prevents suffering from 
external shocks;
• sound risk adjustment methods: consistent system of risk 
adjustment and risk pooling ensure that resources are 
spent according to needs;
• good governance: strong leadership, sound account-
ability mechanisms and a clear organisational struc-
ture enable systems to adapt quickly to new objec-
tives and priorities;
• information flows in the system: monitoring information, 
both at the level of individual patients or healthcare 
providers, enable health systems managers to make 
tailored, evidence-based decisions in specific sub-
sectors;
• adequate costing of health services: the ability to cost 
healthcare services accurately is a prerequisite for ef-
fective decisions on investment;
• a health workforce of adequate capacity and with the right 
skills: it is essential for finding innovative solutions 
through organisational and technological change.
Governments around the world experience tension 
while setting priorities and facing innovations and sus-
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tainability. This tension becomes particularly critical 
when resource allocation for rare diseases is concerned. 
In the framework of the Joint Action for Rare Dis-
eases (Joint RD-Action) “Promoting Implementation 
of Recommendations on Policy, Information and Data 
for Rare Diseases”, a specific task on health systems 
sustainability was defined in order to identify and un-
derstand mechanisms that influence the sustainability, 
equity and resilience of health systems for rare diseases. 
The initial activity of the task included a literature re-
view of the available publications on these issues. It was 
meant to involve policy makers, civil servants in charge 
of national strategies on RDs and all stakeholders in a 
collective responsible approach. 
METHOD
To obtain an overview of sustainability and resilience 
of health systems for rare diseases, we performed a nar-
rative review of the literature to select articles, docu-
ments, and reports on health systems sustainability and 
resilience for rare diseases. 
The following health descriptors were selected: health, 
healthcare organization, sustainability, equity, resilience, 
governance, prevention, citizen/patient/families em-
powerment, rare diseases. The following databases were 
used: PubMed, Scopus, EBSCOHost, EMBAL, PAS-
CAL, EMBASE, STN International and GoogleScholar 
(gray literature). The language of publication was limited 
to English, French, Spanish and Italian, and the year 
started from 2000. As a result of our search, 97 papers 
and 4 grey literature publications were identified.
Publications that met the inclusion criteria were con-
tent-analysed to identify the characteristics of sustainabil-
ity and resilience. The analysis was primarily guided by 
an interpretive synthesis concept, as outlined by Dixon-
Woods [2]. This mind-frame describes a process of aggre-
gating existing concepts and approaches in the literature 
to come to a universal outlook. We applied a thematic 
analysis in this study as the guiding methodology for the 
synthesis of documents. This style of analysis is character-
ized by a clear identification of prominent themes and 
the subsequent re-organization of existing literature un-
der these themes [2]. Accordingly, the characteristics of 
sustainability and resilience were summarized and com-
pared with each other to identify recurring dimensions.
To further integrate the findings, the characteristics 
bearing the same content were clustered under a set 
of thematic areas and were then used to construct a 
framework for sustainability and resilience for rare dis-
eases. The results of the review had been presented and 
discussed in a workshop with representatives of EU 
Member States in charge for Rare Diseases at national 
level, patients’ organizations and professionals from 
public health institutions, in Rome on June 14, 2016.
The results of the workshop had been sent to all Min-
istries of Health representatives in charge for RDs, via 
email to receive additional commentary and to have ul-
timately validation.
RESULTS
The bibliographic search identified 97 papers and 4 
grey literature publications. They were analysed accord-
ing to three main categories: sustainability, equity and 
resilience.
Two main topics stand out from the review: economic 
evaluation and networks. The first topic focuses on the 
available evidence on the adequacy of economic evalua-
tion for decision-making, based upon allocative efficien-
cy for incorporating or excluding technologies for rare 
diseases. There is no widely accepted criterion in the 
literature to weigh the expected utilities, in the sense of 
assigning more weight to individuals with greater health 
needs. Other methodologies are needed to complement 
cost-effectiveness studies, weighting utilities asymmet-
rically (that is, everyone is treated equally) [3].
As far as networks are concerned, the knowledge of 
people’s relationships and the analysis of Social Net-
works in the field of public health was identified as in-
creasingly important. Varieties of healthcare network 
include professional (“expertise”) networks: clinical re-
ferral “care” networks; project networks; “experience” 
networks of users and carers; policy networks (includ-
ing policy “communities”); learning networks; and 
interest networks which promote particular policy or 
interest-group. Many health systems now use networks 
as governance structures. Several countries, such as 
United Kingdom, Netherland, Italy, United States and 
Australia include Patient’s Organizations in health sys-
tems studies, including their sustainability. According 
to Sheaff, et al., networks generate a “macroculture” 
that, on turn, generate practices and activities that can 
affect the community [4]. Network “macroculture” is 
the complex of artefacts, espoused values and unar-
ticulated assumptions through which network mem-
bers coordinate network activities. Knowledge of how 
network macroculture develops is therefore of value 
for understanding how health networks operate, how 
health system reforms affect them, and how networks 
function (and can be used) as governance structures. 
The study carried out by Sheaff and coll. found that 
in these networks, artefacts adapted to health system 
reform faster than espoused values did, and the lat-
ter adapted faster than basic underlying assumptions. 
These findings contribute to knowledge by providing 
empirical support for theories which hold that changes 
in networks’ core practical activity are what stimulate 
changes in other aspects of network macroculture. The 
most powerful way of using network macroculture to 
manage the formation and operation of health net-
works therefore appears to be by focusing managerial 
activity on the ways in which networks produce their 
core artefacts.
As far as sustainability of health systems for RDs is 
concerned, the issue shares additional challenges to 
those faced by healthcare systems. While social and de-
mographic pressures increase demand for health care, 
and technological and scientific advances continue to 
increase costs, in Europe, the financial crisis posed ma-
jor threats to healthcare sustainability. Governments’ 
response to the crisis was cutting public health-care 
budgets, and transferring healthcare costs to individu-
als and families through out-of-pocket payments. As a 
result, not only equity was jeopardized, suffering the 
least wealthy from the greatest health effects, but also 











austerity policies affected economic growth much more 
adversely than previously believed. At the moment, 
the same international institutions imposing austerity 
policies are now advocating public investments to over-
come economic stagnation [5, 6].
The absence of up-to-date morbidity and mortality 
data have clearly made the immediate effects of the 
crisis on health impossible to analyse, leaving policy 
attention focused on economic aspects. Moreover, re-
markably little research has been done about the health 
consequences of the crisis and much of that done has 
been undertaken by individual researchers without ad-
ditional funding [7].
The voices of key stakeholders, the health policy 
community, health-care managers and leaders, national 
governments, and politicians at both a national and 
a European level have not been as influential as they 
should be. Few studies are carried out on health policy 
research, on design of funding systems and their effect 
on financial performance, on health-care quality, and 
health status. 
Groups concerned with biomedicine, pharmaceuti-
cals, and medical technologies are driving the process 
for setting health research priorities, and government 
ministries of science have coordinated them nationally 
with little input from Ministries of Health. Research 
budget at EU level is dominated by biomedical top-
ics: only 4% of the € 642 million EU cooperation pro-
gramme for health research in 2011 was allocated to 
health systems, public health, or health policy research 
[8]. A report recommended that 25% of health research 
budgets should be spent on public health, health sys-
tems, and health policy research [8]. Horizon 2020, 
the biggest EU Research and Innovation programme, 
dedicates 38.53% of its total budget to Societal Chal-
lenges. Yet this issue concerns several fields: health, 
demographic change and wellbeing; food security, 
sustainable agriculture and forestry, marine and mari-
time and inland water research; Bioeconomy; Secure, 
clean and efficient energy; Smart, green and integrated 
transport; Climate action, environment, resource ef-
ficiency and raw materials; inclusive, innovative and 
reflective societies; security of Europe and its citizen. 
Horizon 2020 narrows the interpretation of health and 
wealth agenda, regarding health research as a lever 
for economic growth through exploitable intellectual 
property [9].
As far as resilience is concerned, the financial crisis 
created a set of economic shocks that resulted in widely 
varying policy responses and differing health outcomes, 
and thus has created the basis for future research about 
which policy responses can mitigate risks. Multilevel 
notions of resilience-i.e., how individuals, communi-
ties, and entire societies positively adapt to shocks-an 
provide an explanatory framework that implicates the 
physical, psychosocial, and economic factors that help 
populations to resist and adapt to public health threats, 
such as the economic crisis [7].
Affordability and financial sustainability are the big-
gest issues confronting healthcare providers. Across Eu-
rope, notwithstanding the complexity and differences in 
how healthcare is funded and organised, the countries 
face the same challenges: how to continue to provide 
high quality and universally accessible health services 
in a financially sustainable way. Healthcare expenditure 
is too often seen in a narrow context, purely as an eco-
nomic cost. However, even at economic level, health ex-
penditure properly organised and delivered will reduce 
other welfare costs, and generally improve productivity. 
Evidence demonstrates that significant savings can be 
created by investment in prevention [10, 11] and early 
intervention. Investment in prevention and early inter-
vention is essential for healthcare sustainability and so-
cioeconomic development and stability.
Fostering empowerment and responsibility in citizens 
involves assisting individuals to discover and develop 
the inherent capacity to be more responsible for one’s 
own health. Healthcare systems will be more sustaina-
ble if individuals understand their rights, responsibili-
ties, capabilities and opportunities to remain healthy 
and to manage their own health in the most appropria-
te setting, providing the political and economic context 
empowers them to do so. It must be acknowledged that 
in Europe today many people place a higher priority on 
their immediate survival needs. In addition, challenges 
arise from the fact that healthcare systems are complex, 
so accessing the right care at the right time in the most 
effective way while making the best use of health ser-
vices can be a real challenge.
Strategies to empower patients take place through 
direct pathways, including individual effective decision 
making, management of disease complications, and 
improved health behaviours, and indirectly through 
strengthened support groups, empowerment of caregiv-
ers, and improved access to and efficient use of health 
services. Empowerment strategies require resources and 
capability building that should be driven by the public 
sector (including health and education sectors), family 
doctors, civil society, media, and academia. Information 
sharing, coupled with sustained investment in educa-
tion, will also enable citizens to better understand their 
health condition and participate in the decision-making 
process to plan and manage their own healthcare plans, 
which will result in better outcomes. 
Considering the complexity of policy-making, the 
WHO identified whole-of-government and whole-of-
society approaches as a set of tools to manage the com-
plex policy process and identified the following features 
for comparing good governance practices [12]:
• forward looking: long-term view based on statistical 
trends and informed predictions of the probable im-
pact of the policy;
• innovative: questioning established methods and en-
couraging new ideas;
• informed by evidence: using the best available evi-
dence from a range of sources;
• inclusive: taking account of the impact of the policy 
on the needs of everyone directly or indirectly af-
fected;
• joined-up: horizontal and vertical integration;
• adaptive: learning from experience of what works and 
what does not;
• evaluative: including systematic evaluation;
• accountable: being democratically legitimized, trans-











parent and responsive to the demands of citizens.
Many existing whole-of-government and whole-of-
society approaches focus on communication, cooperation 
and coordination. The final step in whole-of-government 
approaches, collaboration or even integration, in which 
risks, responsibilities and rewards for a common goal 
are shared, seems to be less common and the most dif-
ficult to achieve [1].
While many whole-of-government applications have 
led to a strengthening of central coordination bodies, 
it may be that the cooperation required in whole-of-
government approaches works best at lower levels of 
governance, such as local authorities.
Whole-of-government approaches at this level can 
significantly enhance transparency, accessibility and re-
sponsiveness, as long as institutional arrangements are 
adaptive to change and create accountability to the citi-
zens they serve. At local level, however, the move from 
a whole-of-government to a whole-of-society approach 
through the involvement of many local stakeholders has 
become a strong feature of “smart governance”. 
Despite the centrality of equity in policy, research re-
view highlights that patients’ access or use of healthcare 
services is inequitable. However, while there is an im-
plicit assumption of inequity, there is little evidence to 
support this assumption, as studies rarely assess need 
or demand for services rather than patterns of utiliza-
tion. Moreover, the studies are biased towards issues of 
accountability and deserve little attention to legitimacy 
issues, that concern normative aspects of fairness and 
equity. The real political, economic and ethical question 
is the source of the required financing for health ser-
vices. Very rich countries can still afford to rely largely 
on private health insurance or out-of-pocket payment, 
but this option is seriously hampering equity. Moreover, 
an economic system that is concentrating wealth in the 
hands of a few, calls for political considerations about 
redistribution of resources and wealth. 
DISCUSSION AND POSSIBLE INITIATIVES
Aluttis et al. [14] identified public health capacity 
dimensions in the organizational structure, resources, 
partnership, workforce, knowledge development, lead-
ership and governance and country specific context 
with relevance for public health. 
Health systems sustainability shares several dimen-
sions with WHO/EURO’s Essential Public Health 
Operations [14] and with the public health capacity di-
mensions identified by Aluttis et al. [15], namely orga-
nizational structure, resources, partnership, workforce, 
knowledge development, leadership and governance 
and country specific context with relevance for public 
health. More specifically, the organizational structure 
shapes the infrastructural ability of the system to con-
tribute to the goals to healthcare systems for RDs. Al-
location and provision of human and financial resources 
to healthcare systems for RDs; collaboration among 
organizations for effective practice; qualified human 
resources with adequate skills and knowledge; knowl-
edge development as a base providing information on 
the health status and supporting evidence-based health 
policy and interventions at all levels; leadership and 
governance as ability and willingness of governments to 
improve public health by developing and implementing 
effective health policies and by expressing qualities in 
leadership and strategic thinking; all of them represent 
key elements and mechanisms for the sustainability 
of the health systems for rare diseases. Moreover, the 
political context and other characteristics of a country 
may have an influence on health policies and capacity 
building efforts with relevance for RDs.
A European Steering Group on Sustainable Health-
care identified initiatives for sustainable healthcare 
[16]. According to our literature analysis, a few of the 
initiatives identified by the European Steering Group 
on Sustainable Healthcare could be adapted to health-
care for rare diseases. They address Member States and 
Ministries and concern 1) prevention; 2) empowerment 
ad resilience; 3) integrated care based on patients’ 
pathways and care delivery shifted to community and 
homes. In particular these initiatives suggest to focus 
respectively on:
Prevention
• Governments: to consider health and equity aspects 
in all policies;
• Government ministries: to develop joint budgeting 
mechanisms between ministries and intersectoral ac-
tion, thus addressing the current silo approach1 (e.g. 
health and social affairs, education, and economic 
and budget ministries).
• Member States: to strengthen registries, and develop 
practice guidelines on systematic data collection and 
surveillance, so as to better inform national preven-
tion and treatment strategies.
Empowerment and resilience
• Member States: to fully transpose the Directive on 
the application of patients’ rights in cross-border 
healthcare to improve citizens’ access to information 
on healthcare systems and develop and implement 
information and education programmes for citizens 
on care available;
• National Ministers of Education: in the context of 
prevention campaigns, to integrate early education 
programmes in school curricula addressing health de-
terminants at early stages in life;
• Ministries of Health and Education: to jointly de-
velop programmes aimed at increasing the level of 
health literacy among the general population; 
• Member States: to foster the development of mul-
tidisciplinary partnership and comprehensive ap-
proaches between policymakers, healthcare provid-
ers, community and health planners, patients and 
pharmaceutical companies to address issues with 
regards to rare diseases.
1 A silo mentality can occur when a team or department shares common 
tasks but derives their power and status from their group. They are less 
likely to share resources or ideas with other groups. Collaboration in a 
business culture with silos among teams or departments will be limited, 
unless collaboration benefits the members of the department. In ad-
dition, the members of a silo tend to think alike. They get their power 
from association with their function.











Integrated care based on patients’ pathways and care 
delivery shifted to community and homes
• Member States and European Commission: to create 
a platform of exchange for European and non-Euro-
pean countries’ experiences in establishing healthcare 
systems fit to address chronic care and rare diseases;
• Member States: to develop guidelines and funding 
mechanisms to develop community and home care;
• Member States: to develop integrated care models 
for rare diseases which efficiently link and leverage 
rare disease registries;
• Member States’ governments and healthcare provid-
ers: to conduct frequent performance audits in health 
services to identify opportunities for efficiencies, 
thereby improving their performance and outcome.
Finally, better organisation and management of 
healthcare for RDs is expected not only to decrease 
economic burden but also to enhance quality of life, 
ensuring both sustainability and equity to healthcare 
systems for RDs. Centres of expertise and reference 
networks are a key public health policy tool to address 
health inequalities due to rare diseases in the EU.
CONCLUSIONS
Sustainability of health systems for RDs shares ad-
ditional challenges to those faced by health systems, 
that are stressed by the current financial crisis. Many 
similarities exist between public health capacity and 
sustainability for RDs, and possible mechanisms for en-
suring sustainability can be identified, namely:
• networking;
• patients’ empowerment;
• reorientation of healthcare towards integrated com-
munity and home care.
Both networking and patients’ empowerment rely 
upon community and health systems’ resilience, i.e. 
how individuals, communities, and entire societies 
positively adapt to challenges. The active role of pa-
tients’ representatives is now recognised as a major 
contribution to catalyzing cooperation and sustainable 
development, as well as in its political role of raising 
awareness and advocating at national, EU and inter-
national level.
According to WHO, the following principles should 
be taken into account for complex policy processes:
• identify several initial domains for action as lever 
points for change;
• assemble around each lever point a strategic network 
of key stakeholders from government and civil soci-
ety;
• bring together all the networks created according to 
the lever points within a whole-of-society compact 
that is supported by a platform to share information 
and research and build capacity.
WHO identified two sets of tools to manage the 
complex policy process: a whole-of-government and 
a whole-of-society approach. Both of them are funda-
mental for networking and must be adapted to each 
country’s unique circumstances and background.
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